A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 4, 2014, Pages

  Torekov, S S ^a   Harslof T ^b   Rejnmark, L ^b   Eiken, P ^a   Jensen, J B ^c,d   Herman, A P ^e   Hansen, T ^a   Pedersen, O ^a   Holst, J J ^a   Langdahl, B L ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BONE DENSITY; CLIMACTERIUM; COHORT ANALYSIS; DENMARK; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; FRACTURE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GIPR GENE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

ALLELES; AMINO ACID SUBSTITUTION; BONE DENSITY; COHORT STUDIES; FEMALE; FEMUR NECK; FRACTURES, BONE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RECEPTORS, GASTROINTESTINAL HORMONE;

EID: 84898426818     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3766     Document Type: Article

References (19)

1. Bollag RJ,ZhongQ, Phillips P, et al. Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology . 2000;141:1228-1235.
2. Zhong Q, Itokawa T, Sridhar S, et al. Effects of glucose-dependent insulinotropic peptide on osteoclast function. Am J Physiol Endocrinol Metab . 2007;292:E543-E548.
3. Ding KH, Shi XM, Zhong Q, et al. Impact of glucose-dependent insulinotropic peptide on age-induced bone loss. J Bone Miner Res . 2008;23:536-543.
4. Mieczkowska A, Irwin N, Flatt PR, Chappard D, Mabilleau G. Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality. Bone . 2013;56:337-342.
5. Gaudin-Audrain C, Irwin N, Mansur S, et al. Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice. Bone . 2013; 53:221-230.
6. Fortin JP, Schroeder JC, Zhu Y, Beinborn M, Kopin AS. Pharmacological characterization of human incretin receptor missense variants. J Pharmacol Exp Ther . 2010;332:274-280.
7. Saxena R, HivertMF,Langenberg C, et al. Genetic variation inGIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet . 2010;42:142-148.
8. Sauber J, Grothe J, Behm M, et al. Association of variants in gastric inhibitory polypeptide receptor gene with impaired glucose homeostasis in obese children and adolescents from Berlin. Eur J Endocrinol . 2010;163:259-264.
9. Lyssenko V, Eliasson L, Kotova O, et al. Pleiotropic effects of GIP on islet function involve osteopontin. Diabetes . 2011;60:2424-2433.
10. Mosekilde L, Hermann AP, Beck-Nielsen H, Charles P, Nielsen SP, Sorensen OH. The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women. Maturitas . 1999;31:207-219.
11. Abrahamsen B, Gram J, Hansen TB, Beck-Nielsen H. Cross-calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone . 1995; 16:385-390.
12. McCloskey EV, Spector TD, Eyres KS, Fern ED, ORourke N, Vasikaran S, Kanis JA. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int . 1993;3:138-147.
13. Smit MJ, Vischer HF, Bakker RA, et al. Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. Annu Rev Pharmacol Toxicol . 2007;47:53-87.
14. Bollag RJ, Zhong Q, Ding KH, et al. Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects. Mol Cell Endocrinol . 2001;177:35-41.
15. Tsukiyama K, Yamada Y, Yamada C, et al. Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol Endocrinol . 2006;20:1644-1651.
16. Silverberg SJ, Lindsay R. Postmenopausal osteoporosis. Med Clin North Am . 1987;71:41-57.
17. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res . 1996;11:1043-1051.
18. Estrada K, Styrkarsdottir U, Evangelou E, et al. Genome-wide metaanalysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet . 2012;44:491-501.
19. Paternoster L, Lorentzon M, Lehtimaki T, et al. Genetic determinants of trabecular and cortical volumetric bone mineral densities and bone microstructure. PLoS Genet . 2013;9:e1003247.